clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT02753686 |
P17 | country | Canada | Q16 |
P582 | end time | 2023-01-02 | |
P921 | main subject | multiple endocrine neoplasia | Q1553018 |
P2899 | minimum age | 18 | |
P1132 | number of participants | 500 | |
P4844 | research intervention | tamoxifen | Q412178 |
P1813 | short name | Treat ER+ight | |
P859 | sponsor | Novartis | Q507154 |
P580 | start time | 2016-03-15 | |
P1476 | title | Treatment of Canadian Men and Pre/Postmenopausal Women With ER+ Advanced Breast Cancer in the Real-World Setting With Hormone Therapy ± Targeted Therapy |